Avendus Capital advises NephroPlus and its shareholders on an investment of INR 850 crores from Quadria Capital

Our business has evolved tremendously over the past few years and today we are proud to be one of the fastest growing and most trusted providers of high-quality dialysis to around 30,000 patients. We look forward to expanding in India, our core market, while exploring further opportunities to bring our expertise and clinical excellence to more patients in other global markets. Quadria’s healthcare expertise and capital will put us in an even better position to keep scaling, innovating, and delivering efficient high-quality care.

Quadria’s investment in NephroPlus underscores our ambition to invest in regional champions of Asian healthcare, who are providing high-quality, affordable healthcare to large, under-served populations. NephroPlus has demonstrated its ability to significantly improve health outcomes for its patients, whilst maintaining industry-leading growth and profitability. We look forward to working with their leadership team to continue to expand their footprint, increase access to dialysis services across Asia and accelerate the next phase of growth for NephroPlus.

We would like to welcome Quadria Capital as they join us on the exciting NephroPlus journey. Our partnership with NephroPlus exemplifies Investcorp's strategic investment philosophy, which is centred on identifying and scaling businesses with substantial growth potential. This is also a rare example of backing an Indian healthcare delivery company to become a global player with a carefully thought through international expansion plan. This has been made possible because of the company's world class execution to deliver highest quality dialyses experience in all our markets. We continue to maintain a significant minority stake and maintain strong conviction that the best years of NephroPlus are yet to come.

Ever since our first investment over a decade ago, NephroPlus has consistently demonstrated a unique ability to deliver value to both consumers and investors. NephroPlus is well-poised to be at the forefront of clinical excellence. We are excited to be part of this new chapter and look forward to supporting them in their growth journey.

We are proud to be a part of NephroPlus’ journey over the past 5+ years across two major funding rounds. NephroPlus is delivering best-in-class dialysis services at affordable prices to patients in remote corners of India, Nepal, Philippines and Uzbekistan. We believe NephroPlus’ operational excellence and proven expansion track record, combined with Quadria’s deep healthcare investment experience will propel the business to a new elevated growth trajectory in the coming years.